As one of the most significant IP developments in China, the Fourth Amendment to the PRC Patent Law introduced patent linkage for pharmaceutical patent litigation in China. A full set of rules implementing the patent linkage system has finally been released and immediately came into force in the first week of July.
Please see full publication below for more information.
